ETS Factor ETV5 Activates the Mutant Telomerase Reverse Transcriptase Promoter in Thyroid Cancer
Authors:
- 14 November 2019
- journal article
- research article
- Published by SAGE Publications in Thyroid®
- Vol. 29 (11) , 1623-1633
Abstract
Background: Co-occurrence of TERT (telomerase reverse transcriptase) promoter (TERTp) mutations with BRAF / RAS mutations is associated with significantly more aggressive thyroid cancer. TERTp mutations are hypothesized to generate de novo binding sites for ETS transcription factors, which are themselves activated by BRAF/RAS-stimulated MEK-ERK activity. To date, a detailed study of this mechanism has been limited to only a few cancer types, and we hypothesized that ETS factors involved in TERTp activation could vary between different cancers. Methodology: Here we sought to identify ETS factor(s) required for TERTp activation in thyroid cancer, using a combination of in silico analyses of TCGA data, and experimentation using in vitro thyroid cell models analyzed by quantitative reverse transcription-PCR, immunoprecipitation (IP), chromatin IP, and gene reporter assays. Results: We found that ETV5 was abundantly expressed in papillary thyroid cancers from the TCGA data set, and in thyroid cancer cell line models. Furthermore, ETV5 was found to preferentially bind to the −124 bp(T) TERTp allele and stimulate TERT transcription in thyroid cancer cells devoid of GA binding protein transcription factor (GABP) activity. We also found that ETV5 functionally cooperates with the transcription factor FOXE1 to further enhance TERTp activity, a mechanism that may at least partially explain why FOXE1 represents a significant genetic determinant of thyroid cancer risk. Conclusions: ETS factors that activate mutant TERTp vary between cancer types, and here we show for the first time that ETV5 demonstrates mutant allele-specific affinity for TERTp in thyroid cancer, a property that has previously only been attributable to GABP.Keywords
This publication has 31 references indexed in Scilit:
- The Transcription Factor ETV5 Mediates BRAFV600E-Induced Proliferation and TWIST1 Expression in Papillary Thyroid Cancer CellsNeoplasia, 2018
- Clinical guidance for radioiodine refractory differentiated thyroid cancerClinical Endocrinology, 2017
- The ETS family of oncogenic transcription factors in solid tumoursNature Reviews Cancer, 2017
- Systematic analysis of telomere length and somatic alterations in 31 cancer typesNature Genetics, 2017
- Long-Range Chromatin Interactions Drive Mutant TERT Promoter ActivationCancer Discovery, 2016
- TERT promoter mutations and monoallelic activation of TERT in cancerOncogenesis, 2015
- Mutation of the TERT promoter, switch to active chromatin, and monoallelic TERT expression in multiple cancersGenes & Development, 2015
- The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerScience, 2015
- ETV6‐NTRK3 is a common chromosomal rearrangement in radiation‐associated thyroid cancerCancer, 2013
- Frequency of TERT promoter mutations in human cancersNature Communications, 2013